Dr. Shanta Chitlange



Scientific
Technical
Administrative

 

 

 

 

 

 

 

Scientist 'F'

Division of Clinical Research
Phone : +( 91-22) 2419 2031
Email  : chitlanges@nirrh.res.in

Academic Background

  • MBBS. Nagpur University 1971
  • DGO. Nagpur University ( Obstestrics and Gynecology) 1975
  • MD. Nagpur University ( Obstestrics and Gynecology, 1978


Professional Experience

Junior & Senior Residency Obstetrics and Gynecology, MGIMS Sevagram 1973-1976
Medical Officer in Family Planning Matru Seva Sangh hospital (PHC ) 1979
Scientist NIRRH 1981 - Till date

 

 

 

Research Interests

  • Clinical trials with intrauterine contraceptive devices
  • Clinical trials with steroidal contraceptive like emergency contraceptive pill, injectable contraceptive
  • Studies on Reproductive Tract Infections (RTIs)
  • Phase I to Phase III trials with Microbicides
  • Maternal and child health
  • Ultrasound based clinical research

Awards & Achievements

  • Awarded fellowship by Indian National Science Academy under INSA-DFG bilateral exchange programme of Scientists, Germany , November – December 2001.
  • Best poster award on Sexual behavior in Cu-T users- International Conference on Reproductive Health, Mumbai. March 1998.

Publications (Last 10)

  1. SM Chiltange , JV Joshi, Anaphylaxis after oral spasmindon (case report). J.of Therapeutics and Drugs Aushadi 9:8, 1993.

  2. SM Chiltange , RS Shah, KT Hazari, TC Anandkumar, CP Puri. Ultrasonographic monitoring of ovarian follicles in women using norethisterone for contraception. Int. J.of Gynecol. & Obst. 53: (1996) 31.

  3. VV Palayekar, JV Joshi, KT Hazari, RS Shah, SM Chitlange . Chlamydia trachomatis detected in cervical smears from Cu-T users by DFA test. Advances in contraception 12: (1996) 145-52.

  4. RS Shah, J Joshi, K Hazari, S Chitlange , R Shah, P Vaidya, M Purandare. Does lactation affect intrauterine device performance? The J. of Family Welfare 44(4): (1998) 62-65.

  5. SM Chitlange , Sexual behavior and Contraception: Knowledge and Practices among Married women. News and Views (Council of Sex Education and parenthood International) 51:36-46, 1999, also best poster award.

  6. VV Palayekar, JV Joshi, KT Hazari, RS Shah, SM Chitlange . Comparison of 4 non culture diagnostic tests for chlamydia trachomatis infection. JAPI 48(5): (2000) 481-483.

  7. Shah RS, Kalgutkar S, Savardekar L, Chitlange S , Iddya U and Balaiah D. Menopausal symptoms in urban Indian women. Obstet. and Gynaecol. Today 9:667-670,2004.

  8. KT Hazari, SM Chitlange . Barrier Contraceptives: Female Condoms, Diaphragms, Cervical Caps . FOGSI Book Chapter on Contraception- Past, Present and Future, pages 73-84, January 2006.

  9. IM Malonza, F Mirembe, C Nakabitto, LO Odusoga, OA Osiupebic, KT Hazari, SM Chitlange , MA Ali, M Callahan, Van Damme L. Expanded Phase I Safety and Acceptability study of 6% cellulose sulfate vaginal gel. AIDS Journal, 19: (18), 2157-2163, 2005.

  10. Madhura Narkar, Sanjeev Kholkute, Shanta Chitlange, Tarala Nandedkar. Expression of steroid hormone receptors, proliferation and apoptotic markers in primate endometrium. Molecular and Cellular Endocrinology. 246: 107-113,2006.

Projects

  • Acceptability and Continuation Rates of 2 Monthly Injectable Contraceptive- Norethisterone Enanthate (Funded by Ministry of Health & Family Welfare, Government of India )

  • Bone Mass Density (BMD) evaluation by DEXA among injection Norethisterone Enanthate users (Funded by Ministry of Health & Family Welfare, Government of India)